|
1
|
Cardoso FL, Brites D and Brito MA: Looking
at the blood-brain barrier: Molecular anatomy and possible
investigation approaches. Brain Res Rev. 64:328–363. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tam SJ and Watts RJ: Connecting vascular
and nervous system development: Angiogenesis and the blood-brain
barrier. Annu Rev Neurosci. 33:379–408. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hawkins BT and Davis TP: The blood-brain
barrier/neurovascular unit in health and disease. Pharmacol Rev.
57:173–185. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bauer HC, Traweger A, Zweimueller-Mayer J,
Lehner C, Tempfer H, Krizbai I, Wilhelm I and Bauer H: New aspects
of the molecular constituents of tissue barriers. J Neural Transm
(Vienna). 118:7–21. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Eichler AF, Chung E, Kodack DP, Loeffler
JS, Fukumura D and Jain RK: The biology of brain
metastases-translation to new therapies. Nat Rev Clin Oncol.
8:344–356. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Furuse M, Fujita K, Hiiragi T, Fujimoto K
and Tsukita S: Claudin-1 and −2: Novel integral membrane proteins
localizing at tight junctions with no sequence similarity to
occludin. J Cell Biol. 141:1539–1550. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ohtsuki S, Yamaguchi H, Katsukura Y,
Asashima T and Terasaki T: mRNA expression Levels of tight junction
protein genes in mouse brain capillary endothelial cells highly
purified by magnetic cell sorting. J Neurochem. 104:147–154.
2008.PubMed/NCBI
|
|
8
|
Nitta T, Hata M, Gotoh S, Seo Y, Sasaki H,
Hashimoto N, Furuse M and Tsukita S: Size-selective loosening of
the blood-brain barrier in claudin-5-deficient mice. J Cell Biol.
161:653–660. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ouban A and Ahmed AA: Claudins in human
cancer: A review. Histol Histopathol. 25:83–90. 2010.PubMed/NCBI
|
|
10
|
Zamore PD and Haley B: Ribo-gnome: The big
world of small RNAs. Science. 309:1519–1524. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Guttman M, Amit I, Garber M, French C, Lin
MF, Feldser D, Huarte M, Zuk O, Carey BW, Cassady JP, et al:
Chromatin signature reveals over a thousand highly conserved large
non-coding RNAs in mammals. Nature. 458:223–227. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: The ceRNA hypothesis: The rosetta stone of a hidden
RNA language. Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Karreth FA, Tay Y, Perna D, Ala U, Tan SM,
Rust AG, DeNicola G, Webster KA, Weiss D, Perez-Mancera PA, et al:
In vivo identification of tumor-suppressive PTEN ceRNAs in an
oncogenic BRAF-induced mouse model of melanoma. Cell. 147:382–395.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tay Y, Kats L, Salmena L, Weiss D, Tan SM,
Ala U, Karreth F, Poliseno L, Provero P, Di Cunto F, et al:
Coding-independent regulation of the tumor suppressor PTEN by
competing endogenous mRNAs. Cell. 147:344–357. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang J, Liu X, Wu H, Ni P, Gu Z, Qiao Y,
Chen N, Sun F and Fan Q: CREB up-regulates long non-coding RNA,
HULC expression through interaction with microRNA-372 in liver
cancer. Nucleic Acids Res. 38:5366–5383. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fan M, Li X, Jiang W, Huang Y, Li J and
Wang Z: A long non-coding RNA, PTCSC3, as a tumor suppressor and a
target of miRNAs in thyroid cancer cells. Exp Ther Med.
5:1143–1146. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Panzitt K, Tschernatsch MM, Guelly C,
Moustafa T, Stradner M, Strohmaier HM, Buck CR, Denk H, Schroeder
R, Trauner M and Zatloukal K: Characterization of HULC, a novel
gene with striking up-regulation in hepatocellular carcinoma, as
noncoding RNA. Gastroenterology. 132:330–342. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jendrzejewski J, He H, Radomska HS, Li W,
Tomsic J, Liyanarachchi S, Davuluri RV, Nagy R and de la Chapelle
A: The polymorphism rs944289 predisposes to papillary thyroid
carcinoma through a large intergenic noncoding RNA gene of tumor
suppressor type. Proc Natl Acad Sci. 109:pp. 8646–8651. 2012;
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Johnsson P, Ackley A, Vidarsdottir L, Lui
WO, Corcoran M, Grandér D and Morris KV: A pseudogene
long-noncoding-RNA network regulates PTEN transcription and
translation in human cells. Nat Struct Mol Biol. 20:440–446. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Prieto C, Risueño A, Fontanillo C and De
las Rivas J: Human gene coexpression landscape: Confident network
derived from tissue transcriptomic profiles. PLoS One. 3:e39112008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cai H, Xue Y, Wang P, Wang Z, Li Z, Hu Y,
Li Z, Shang X and Liu Y: The long noncoding RNA TUG1 regulates
blood-tumor barrier permeability by targeting miR-144. Oncotarget.
6:19759–19779. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhao L, Wang P, Liu Y, Ma J and Xue Y:
miR-34c Regulates the permeability of blood-tumor barrier via
MAZ-mediated expression changes of ZO-1, Occludin, and Claudin-5. J
Cell Physiol. 230:716–731. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Miao YS, Zhao YY, Zhao LN, Wang P, Liu YH,
Ma J and Xue YX: MiR-18a increased the permeability of BTB via
RUNX1 mediated down-regulation of ZO-1, occludin and claudin-5.
Cell Signal. 27:156–167. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Guo J, Cai H, Zheng J, Liu X, Liu Y, Ma J,
Que Z, Gong W, Gao Y, Tao W and Xue Y: Long non-coding RNA NEAT1
regulates permeability of the blood-tumor barrier via
miR-181d-5p-mediated expression changes in ZO-1, occludin, and
claudin-5. Biochim Biophys Acta. 1863:2240–2254. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yu H, Xue Y, Wang P, Liu X, Ma J, Zheng J,
Li Z, Li Z, Cai H and Liu Y: Knockdown of long non-coding RNA XIST
increases blood-tumor barrier permeability and inhibits glioma
angiogenesis by targeting miR-137. Oncogenesis. 6:e3032017.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ma J, Wang P, Yao Y, Liu Y, Li Z, Liu X,
Li Z, Zhao X, Xi Z, Teng H, et al: Knockdown of long non-coding RNA
MALAT1 increases the blood-tumor barrier permeability by
up-regulating miR-140. Biochim Biophys Acta. 1859:324–338. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang S, Li HJ, Wang J, Wang D, Yao A and
Li Q: Prognostic and biological significance of microRNA-127
expression in human breast cancer. Dis Markers. 2014:4019862014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang J, Hou W, Chai M, Zhao H, Jia J, Sun
X, Zhao B and Wang R: MicroRNA-127-3p inhibits proliferation and
invasion by targeting SETD8 in human osteosarcoma cells. Biochem
Biophys Res Commun. 469:1006–1011. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shi L, Wang Y, Lu Z, Zhang H, Zhuang N,
Wang B, Song Z, Chen G, Huang C, Xu D, et al: miR-127 promotes EMT
and stem-like traits in lung cancer through a feed-forward
regulatory loop. Oncogene. 36:1631–1643. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Huan L, Bao C, Chen D, Li Y, Lian J, Ding
J, Huang S, Liang L and He X: MicroRNA-127-5p targets the
biliverdin reductase B/nuclear factor-κB pathway to suppress cell
growth in hepatocellular carcinoma cells. Cancer Sci. 107:258–266.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sun Y, Zhao J, Yin X, Yuan X, Guo J and Bi
J: miR-297 acts as an oncogene by targeting GPC5 in lung
adenocarcinoma. Cell Prolif. 49:636–643. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang Y and Kong D: Knockdown of lncRNA
MEG3 inhibits viability, migration, and invasion and promotes
apoptosis by sponging miR-127 in osteosarcoma cell. J Cell Biochem.
119:669–679. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bai Y, Zhang Y, Hua J, Yang X, Zhang X,
Duan M, Zhu X, Huang W, Chao J, Zhou R, et al: Silencing
microRNA-143 protects the integrity of the blood-brain barrier:
Implications for methamphetamine abuse. Sci Rep. 6:356422016.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Brastianos PK, Carter SL, Santagata S,
Cahill DP, Taylor-Weiner A, Jones RT, Van Allen EM, Lawrence MS,
Horowitz PM, Cibulskis K, et al: Genomic characterization of brain
metastases reveals branched evolution and potential therapeutic
targets. Cancer Discov. 5:1164–1177. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chen G, Chakravarti N, Aardalen K, Lazar
AJ, Tetzlaff MT, Wubbenhorst B, Kim SB, Kopetz S, Ledoux AA, Gopal
YN, et al: Molecular profiling of patient-matched brain and
extracranial melanoma metastases implicates the PI3K pathway as a
therapeutic target. Clin Cancer Res. 20:5537–5546. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li Q, Yang J, Yu Q, Wu H, Liu B, Xiong H,
Hu G, Zhao J, Yuan X and Liao Z: Associations between
single-nucleotide polymorphisms in the PI3K-PTEN-AKT-mTOR pathway
and increased risk of brain metastasis in patients with non-small
cell lung cancer. Clin Cancer Res. 19:6252–6260. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Piontek J, Winkler L, Wolburg H, Müller
SL, Zuleger N, Piehl C, Wiesner B, Krause G and Blasig IE:
Formation of tight junction: Determinants of homophilic interaction
between classic claudins. FASEB J. 22:146–158. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wilhelm I, Molnár J, Fazakas C, Haskó J
and Krizbai IA: Role of the blood-brain barrier in the formation of
brain metastases. Int J Mol Sci. 14:1383–1411. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Huang W, Rha GB, Chen L, Seelbach MJ,
Zhang B, András IE, Bruemmer D, Hennig B and Toborek M: Inhibition
of telomerase activity alters tight junction protein expression and
induces transendothelial migration of HIV-1-infected cells. Am J
Physiol Heart Circ Physiol. 298:H1136–1145. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Armando RG, Gomez DM and Gomez DE: AZT
exerts its antitumoral effect by telomeric and non-telomeric
effects in a mammary adenocarcinoma model. Oncol Rep. 36:2731–2736.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yang Y and Rosenberg GA: MMP-mediated
disruption of claudin-5 in the blood-brain barrier of rat brain
after cerebral ischemia. Methods Mol Biol. 762:333–345. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
De Lorenzo MS, Alonso DF and Gomez DE:
Nafoxidine modulates the expression of matrix-metalloproteinase-2
(MMP-2) and tissue inhibitor of metalloproteinases-1 (TIMP-1) in
endothelial cells. Anticancer Res. 20(1A): 1–400. 2000.PubMed/NCBI
|
|
43
|
Cyr M, Calon F, Morissette M and Di Paolo
T: Estrogenic modulation of brain activity: implications for
schizophrenia and Parkinson's disease. J Psychiatry Neurosci.
27:12–27. 2002.PubMed/NCBI
|
